Related Experiment Video
Updated: Jun 22, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Maja Rupnik1, Mark H Wilcox, Dale N Gerding
1Institute of Public Health Maribor, Centre for Microbiology, Prvomajska 1, 2000 Maribor, Slovenia. maja.rupnik@uni-mb.si
Abstract:
Clostridium difficile is now considered to be one of the most important causes of health care-associated infections. C. difficile infections are also emerging in the community and in animals used for food, and are no longer viewed simply as unpleasant complications that follow antibiotic therapy. Since 2001, the prevalence and severity of C. difficile infection has increased significantly, which has led to increased research interest and the discovery of new virulence factors, and has expanded and focused the development of new treatment and prevention regimens. This Review summarizes the recent epidemiological changes in C. difficile infection, our current knowledge of C. difficile virulence factors and the clinical outcomes of C. difficile infection.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Bacterial Gastroenteritis
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease III: Crohn's Disease
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Toxins
